BN Business News
Add your company to Business Communicator →

Zdrowie i gospodarka · 04/03/2021

FDA Withdraws BELVIQ Tablets and XR Tablets from Sale

The Food and Drug Administration has withdrawn BELVIQ tablets and XR tablets from sale due to safety or effectiveness concerns, and will not accept new applications for these medications.

Source: Federal Register — Food and Drug AdministrationOpen original release →